20 results
8-K
EX-10.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
, formulation, means of delivery, packaging or dosage of such compound, product or technology, any discovery or development of any new or expanded
8-K
EX-99.2
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring, and post-approval … the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency. Additionally, appropriate packaging
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage … , appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage … . Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does
DEFA14A
lrz69z794 c4i
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-2.1
5gopimvmrifor o3p1
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
10-K
sa8 7i6ag
7 Mar 22
Annual report
4:03pm
424B4
r053zydviq
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
n5eulqpj
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-1.1
r8ta7tm43e2 ch5
2 Aug 21
IPO registration (amended)
6:08am
S-1
i0m3am03pk4fr0 2u67a
16 Jul 21
IPO registration
5:02pm
DRS/A
5i49flx2
12 Jul 21
Draft registration statement (amended)
12:00am
DRS/A
uhnjku1d9e0piua9oc71
21 Jun 21
Draft registration statement (amended)
12:00am
DRS
vj6ra0845qn
12 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next